[Novocainamide in the treatment of paroxysmal supraventricular tachycardia and auricular fibrillation in premature ventricular excitation syndrome (relation between novocainamide dose, its blood level, and antiarrhythmia effect)].
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011342:Procainamide / Q000008:administration & dosage* / Q000097:blood; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy* / Q000209:etiology; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications*
D011342:Procainamide
Novokainamid v lechenii paroksizmov supraventrikuliarnoĭ takhikardii i mertsatel'noĭ aritmii pri sindrome prezhdevremennogo vozbuzhdeniia zheludochkov (zavisimost' mezhdu dozoĭ novokainamida, ego kontsentratsieĭ v plazme i antiaritmicheskim éffektom).